第一工業製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4461/E00885 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/03/19 | 日証協 | 59,381株 | -22.27% | 18,736株 | +1.28% | 53,401株 | -16.1% | 17,301株 | -65.26% |
2021/03/12 | 日証協 | 76,397株 | -12.86% | 18,500株 | -24.18% | 63,648株 | -6.11% | 49,800株 | +132.3% |
2021/03/05 | 日証協 | 87,676株 | +9.55% | 24,400株 | +17.87% | 67,788株 | -1.07% | 21,438株 | +119.92% |
2021/02/26 | 日証協 | 80,036株 | +30.7% | 20,700株 | -55.86% | 68,518株 | +18.1% | 9,748株 | -74.22% |
2021/02/19 | 日証協 | 61,236株 | +0.63% | 46,900株 | +241.74% | 58,018株 | -23.01% | 37,808株 | +256.81% |
2021/02/12 | 日証協 | 60,852株 | -20.51% | 13,724株 | -52.84% | 75,358株 | -14.2% | 10,596株 | -68.6% |
2021/02/05 | 日証協 | 76,552株 | -11.35% | 29,100株 | +22.27% | 87,828株 | -42.22% | 33,740株 | +32.33% |
2021/01/29 | 日証協 | 86,352株 | -24.02% | 23,800株 | +172.31% | 152,014株 | -9.74% | 25,496株 | +104.16% |
2021/01/22 | 日証協 | 113,652株 | -18.39% | 8,740株 | -35.74% | 168,414株 | -6.96% | 12,488株 | +30.79% |
2021/01/15 | 日証協 | 139,254株 | +0.43% | 13,600株 | -65.48% | 181,016株 | +0.95% | 9,548株 | -48.38% |
2021/01/08 | 日証協 | 138,654株 | -14.7% | 39,400株 | +93.14% | 179,316株 | -9.94% | 18,497株 | +22.18% |
2020/12/30 | 日証協 | 162,554株 | +3.24% | 20,400株 | +50% | 199,115株 | -1.63% | 15,139株 | -53.56% |
2020/12/25 | 日証協 | 157,454株 | -10.24% | 13,600株 | +134% | 202,424株 | -1.89% | 32,596株 | +218.07% |
2020/12/18 | 日証協 | 175,414株 | -0.84% | 5,812株 | -71.92% | 206,324株 | -1.01% | 10,248株 | -61.32% |
2020/12/11 | 日証協 | 176,902株 | +3.15% | 20,700株 | +77.53% | 208,424株 | -2.6% | 26,496株 | -2.94% |
2020/12/04 | 日証協 | 171,502株 | -1.89% | 11,660株 | +39.47% | 213,978株 | -2.39% | 27,298株 | +95.71% |
2020/11/27 | 日証協 | 174,802株 | +3.01% | 8,360株 | -65.74% | 219,227株 | -0.5% | 13,948株 | -27.72% |
2020/11/20 | 日証協 | 169,702株 | -2.86% | 24,400株 | -50.53% | 220,327株 | -2.61% | 19,296株 | -39.79% |
2020/11/13 | 日証協 | 174,702株 | +2.61% | 49,327株 | +28.08% | 226,227株 | -1.29% | 32,048株 | -32.25% |
※株式分割は考慮していませんのでご注意ください。
Page Top